Comparison of bone marrow versus peripheral blood allogeneic hematopoietic stem cell transplantation for hematological malignancies in adults—a systematic review and meta-analysis

Gratwohl, 2002, Current trends in hematopoietic stem cell transplantation in Europe, Blood, 100, 2374, 10.1182/blood-2002-03-0675 Anasetti, 2012, Peripheral-blood stem cells versus bone marrow from unrelated donors, N Engl J Med, 367, 1487, 10.1056/NEJMoa1203517 Bensinger, 2001, Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers, N Engl J Med, 344, 175, 10.1056/NEJM200101183440303 Blaise D KMFCBJHMNSLJJPAMBPCJ. Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle. J Clin Oncol. 2000;18(3):537–46. Champlin, 2000, Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR histocompatibility and stem cell sources working committee and the European Group for Blood and Marrow Transplantation (EBMT), Blood, 95, 3702 Cornelissen Jj vdHBPEJVLRCAHMMJSHCB. A randomized multicenter comparison of CD34(+)-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies. Exp Hematol 2003;31(10):855–64. Couban, 2002, A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies, Blood, 100, 1525, 10.1182/blood-2002-01-0048 Didier Blaise, 2000, Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle, J Clin Oncol, 18, 537, 10.1200/JCO.2000.18.3.537 Eapen, 2007, Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival, Biol Blood Marrow Transplant, 13, 1461, 10.1016/j.bbmt.2007.08.006 Flowers, 2002, Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial, Blood, 100, 415, 10.1182/blood-2002-01-0011 Friedrichs, 2010, Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial, Lancet Oncol, 11, 331, 10.1016/S1470-2045(09)70352-3 Gallardo, 2009, Is mobilized peripheral blood comparable with bone marrow as a source of hematopoietic stem cells for allogeneic transplantation from HLA-identical sibling donors? A case-control study, Haematologica, 94, 1282, 10.3324/haematol.2009.006924 Heldal, 2003, Fewer relapses and increased chronic GVHD in patients transplanted with blood stem cells: a 5-year follow-up in a single centre study, Bone Marrow Transplant, 32, 257, 10.1038/sj.bmt.1704127 Mahmoud, 1999, Peripheral blood vs bone marrow as a source for allogeneic hematopoietic stem cell transplantation, Bone Marrow Transplant, 24, 355, 10.1038/sj.bmt.1701906 Mark Kirschbaum, O’Donnell M, Spielberger R, Bhatia R, Pullarkat V, Stein A, et al. Peripheral blood stem cells vs bone marrow for matched sibling transplant in AML and ALL remission. Blood.104(11 abstract 3321). Mielcarek M, Storer B, Martin PJ, Forman SJ, Negrin RS, Flowers ME, et al. Long-term outcomes after transplantation of HLA-identical related G-CSF-mobilized peripheral blood mononuclear versus bone marrow. Blood 119:2675–8. Mohty, 2002, Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study, Blood, 100, 3128, 10.1182/blood.V100.9.3128 Nagafuji, 2010, Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia: a propensity score-based comparison from the Japan society for hematopoietic stem cell transplantation registry, Int J Hematol, 91, 855, 10.1007/s12185-010-0581-1 Oehler, 2005, Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemia, Biol Blood Marrow Transplant, 11, 85, 10.1016/j.bbmt.2004.09.010 Powles, 2000, Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial, Lancet, 355, 1231, 10.1016/S0140-6736(00)02090-0 Ringden, 2002, Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia, J Clin Oncol, 20, 4655, 10.1200/JCO.2002.12.049 Ringden, 2012, Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukaemia, an acute leukaemia working party analysis in 2262 patients, J Intern Med, 272, 472, 10.1111/j.1365-2796.2012.02547.x Schmitz, 2005, BMBARTNAGERNAJSJBKBA. Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial, Haematologica, 90, 643 Schmitz, 2006, Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the international bone marrow transplant registry and the European group for blood and marrow transplantation, Blood, 108, 4288, 10.1182/blood-2006-05-024042 Vigorito, 1998, A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies, Bone Marrow Transplant, 22, 1145, 10.1038/sj.bmt.1701510 Vigorito, 2001, A randomized, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of hematologic malignancies: an update, Haematologica, 86, 665 Chang, 2012, Allogeneic bone marrow transplantation compared to peripheral blood stem cell transplantation for the treatment of hematologic malignancies: a meta-analysis based on time-to-event data from randomized controlled trials, Ann Hematol, 91, 427, 10.1007/s00277-011-1299-8 Stem Cell Trialists’ Collaborative Croup. Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematological malignancies: an individual patient data meta-analysis of nine randomised trials. J Clin Oncol 2005;23:5074–87. Gratwohl, 2013, Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a global observational study, Haematologica, 98, 1282, 10.3324/haematol.2012.076349 Gratwohl, 2009, The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies, Bone Marrow Transplant, 43, 275, 10.1038/bmt.2009.7 Pasquini MC, Wang Z. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR summary slides. 〈http://www.cibmtr.org.〉; 2013. Pidala, 2009, Decision analysis of peripheral blood versus bone marrow hematopoietic stem cells for allogeneic hematopoietic cell transplantation, Biol Blood Marrow Transplant, 15, 1415, 10.1016/j.bbmt.2009.07.009 Bensinger, 2012, Allogeneic transplantation: peripheral blood vs. bone marrow, Curr Opin Oncol, 24, 191, 10.1097/CCO.0b013e32834f5c27 Parmar, 1998, Extracting summary statistics to perform meta-analyzes of the published literature for survival endpoints, Stat Med, 17, 2815, 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8 Tierney, 2007, Practical methods for incorporating summary time-to-event data into meta-analysis, Trials, 8, 16, 10.1186/1745-6215-8-16 Appelbaum, 2007, Hematopoietic-cell transplantation at 50, N Engl J Med, 357, 1472, 10.1056/NEJMp078166 Ferrara, 2009, Graft-versus-host disease, Lancet, 373, 1550, 10.1016/S0140-6736(09)60237-3 Abrahamson, 2005, Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease, Haematologica, 90, 86 Cao, 2005, Engraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic cell transplantation is affected by CD8+ T-cell dose, Blood, 105, 2300, 10.1182/blood-2004-04-1473 Hassan, 1996, Comparison of the content and subpopulations of CD3 and CD34 positive cells in bone marrow harvests and G-CSF-mobilized peripheral blood leukapheresis products from healthy adult donors, Transpl Immunol, 4, 319, 10.1016/S0966-3274(96)80054-2 Panse, 2005, Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after non-myeloablative conditioning, Br J Haematol, 128, 659, 10.1111/j.1365-2141.2005.05363.x Nagler, 2012, Biol Blood Marrow Transplant, 18, 1422, 10.1016/j.bbmt.2012.02.013 De Souza, 2002, Quality of life in patients randomized to receive a bone marrow or a peripheral blood allograft, Haematologica, 87, 1281 Norkin, 2012, Quality of life, social challenges, and psychosocial support for long-term survivors after allogeneic hematopoietic stem-cell transplantation, Semin Hematol, 49, 104, 10.1053/j.seminhematol.2011.10.004